Please Wait
Applying Filters...
Menu
$ API Ref.Price (USD/KG) : 6,826Xls
Filters Filter
Cross PopUp
FILTER :

filter clear-filterReset all filters

01 10Xalkori

PharmaCompass

01

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

02

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

03

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

04

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

05

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

Brand Name : Xalkori

arrow
AGGSpend
Not Confirmed

Crizotinib

Main Therapeutic Indication : Oncology

Currency : USD

2023 Revenue in Millions : 374

2022 Revenue in Millions : 465

Growth (%) : -20

blank

06

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

07

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

Brand Name : Xalkori

arrow
AGGSpend
Not Confirmed

Crizotinib

Main Therapeutic Indication : Oncology

Currency : USD

2015 Revenue in Millions : 438

2014 Revenue in Millions : 488

Growth (%) : 11%

blank

08

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

Brand Name : Xalkori

arrow
AGGSpend
Not Confirmed

Crizotinib

Main Therapeutic Indication : Oncology

Currency : USD

2016 Revenue in Millions : 561

2015 Revenue in Millions : 488

Growth (%) : 15

blank

09

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

10

Brand Name : Xalkori

Crizotinib

arrow
AGGSpend
Not Confirmed

Brand Name : Xalkori

arrow
AGGSpend
Not Confirmed

Crizotinib

Main Therapeutic Indication : Oncology

Currency : USD

2018 Revenue in Millions : 524

2017 Revenue in Millions : 594

Growth (%) : -12%

blank